HIV-1 vpu antagonizes CD317/tetherin by adaptor protein-1-mediated exclusion from virus assembly sites

Journal of Virology

Volumn 90, Issue 15, 2016, Pages 6709-6723

  Pujol, François M ^a   Laketa, Vibor ^a,b   Schmidt, Florian ^a   Mukenhirn, Markus ^a,c   Müller, Barbara ^a   Boulant, Steeve ^a,c   Grimm, Dirk ^a   Keppler, Oliver T ^d   Fackler, Oliver T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; TETHERIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VPU PROTEIN; ADAPTOR PROTEIN; BST2 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LEUKOCYTE ANTIGEN; VIRAL PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTEROGRADE TRANSPORT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA INTERFERENCE; VIRUS ASSEMBLY; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; HELA CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SEQUENCE HOMOLOGY; VIRION; VIROLOGY; VIRUS RELEASE;

ADAPTOR PROTEIN COMPLEX 1; AMINO ACID SEQUENCE; ANTIGENS, CD; CELL MEMBRANE; GPI-LINKED PROTEINS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PROTEIN TRANSPORT; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84982791064     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00504-16     Document Type: Article

References (69)

1. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401. http://dx.doi.org/10.1038/34929.
2. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338-342. http://dx.doi.org/10.1038/nm0396-338.
3. Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E. 2010. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 8:397-409. http://dx.doi.org/10.1016/j.chom.2010.10.008.
4. Simon V, Bloch N, Landau NR. 2015. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat Immunol 16:546-553. http://dx.doi.org/10.1038/ni.3156.
5. Bishop KN, Holmes RK, Sheehy AM, Malim MH. 2004. APOBEC-mediated editing of viral RNA. Science 305:645. http://dx.doi.org/10.1126/science.1100658.
6. 2/M arrest and escape from innate immune sensing. Cell 156:134-145. http://dx.doi.org/10.1016/j.cell.2013.12.011.
7. Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, Santoni FA, Pizzato M. 2015. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526:212-217. http://dx.doi.org/10.1038/nature15399.
8. Usami Y, Wu Y, Gottlinger HG. 2015. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526:218-223. http://dx.doi.org/10.1038/nature15400.
9. Willey RL, Maldarelli F, Martin MA, Strebel K. 1992. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 66:7193-7200.
10. Haller C, Muller B, Fritz JV, Lamas-Murua M, Stolp B, Pujol FM, Keppler OT, Fackler OT. 2014. HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J Virol 88:14241-14257. http://dx.doi.org/10.1128/JVI.02333-14.
11. Matheson NJ, Sumner J, Wals K, Rapiteanu R, Weekes MP, Vigan R, Weinelt J, Schindler M, Antrobus R, Costa AS, Frezza C, Clish CB, Neil SJ, Lehner PJ. 2015. Cell surface proteomic map of HIV infection reveals antagonism of amino acid metabolism by Vpu and Nef. Cell Host Microbe 18:409-423. http://dx.doi.org/10.1016/j.chom.2015.09.003.
12. Bolduan S, Hubel P, Reif T, Lodermeyer V, Hohne K, Fritz JV, Sauter D, Kirchhoff F, Fackler OT, Schindler M, Schubert U. 2013. HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A. Virology 440:190-203. http://dx.doi.org/10.1016/j.virol.2013.02.021.
13. Chen J, Tibroni N, Sauter D, Galaski J, Miura T, Alter G, Mueller B, Haller C, Walker BD, Kirchhoff F, Brumme ZL, Ueno T, Fackler OT. 2015. Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma. PLoS One 10:e0120434. http://dx.doi.org/10.1371/journal.pone.0120434.
14. Galaski J, Ahmad F, Tibroni N, Pujol FM, Muller B, Schmidt RE, Fackler OT. 2016. Cell surface downregulation of NK cell ligands by patient-derived HIV-1 Vpu and Nef alleles. J Acquir Immune Defic Syndr 72:1-10. http://dx.doi.org/10.1097/QAI.0000000000000917.
15. Cerboni C, Neri F, Casartelli N, Zingoni A, Cosman D, Rossi P, Santoni A, Doria M. 2007. Human immunodeficiency virus 1 Nef protein down-modulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 88:242-250. http://dx.doi.org/10.1099/vir.0.82125-0.
16. Neil SJ, Eastman SW, Jouvenet N, Bieniasz PD. 2006. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog 2:e39. http://dx.doi.org/10.1371/journal.ppat.0020039.
17. Neil SJ, Zang T, Bieniasz PD. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430. http://dx.doi.org/10.1038/nature06553.
18. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3:245-252. http://dx.doi.org/10.1016/j.chom.2008.03.001.
19. Galao RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ. 2012. Innate sensing of HIV-1 assembly by tetherin induces NF-B-dependent proinflammatory responses. Cell Host Microbe 12:633-644. http://dx.doi.org/10.1016/j.chom.2012.10.007.
20. Galao RP, Pickering S, Curnock R, Neil SJ. 2014. Retroviral retention activates a Syk-dependent HemITAM in human tetherin. Cell Host Microbe 16:291-303. http://dx.doi.org/10.1016/j.chom.2014.08.005.
21. Cocka LJ, Bates P. 2012. Identification of alternatively translated tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog 8:e1002931. http://dx.doi.org/10.1371/journal.ppat.1002931.
22. Tokarev A, Suarez M, Kwan W, Fitzpatrick K, Singh R, Guatelli J. 2013. Stimulation of NF-B activity by the HIV restriction factor BST2. J Virol 87:2046-2057. http://dx.doi.org/10.1128/JVI.02272-12.
23. Alvarez RA, Hamlin RE, Monroe A, Moldt B, Hotta MT, Rodriguez Caprio G, Fierer DS, Simon V, Chen BK. 2014. HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells. J Virol 88:6031-6046. http://dx.doi.org/10.1128/JVI.00449-14.
24. + T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2. Retrovirology 11:15. http://dx.doi.org/10.1186/1742-4690-11-15.
25. Veillette M, Desormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, Guan Y, Lewis G, Ferrari G, Hahn BH, Haynes BF, Robinson JE, Kaufmann DE, Bonsignori M, Sodroski J, Finzi A. 2014. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. J Virol 88:2633-2644. http://dx.doi.org/10.1128/JVI.03230-13.
26. Arias JF, Heyer LN, von Bredow B, Weisgrau KL, Moldt B, Burton DR, Rakasz EG, Evans DT. 2014. Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. Proc Natl Acad Sci USA 111:6425-6430. http://dx.doi.org/10.1073/pnas.1321507111.
27. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, Banting G. 2003. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4:694-709. http://dx.doi.org/10.1034/j.1600-0854.2003.00129.x.
28. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD. 2009. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139:499-511. http://dx.doi.org/10.1016/j.cell.2009.08.039.
29. Venkatesh S, Bieniasz PD. 2013. Mechanism of HIV-1 virion entrapment by tetherin. PLoS Pathog 9:e1003483. http://dx.doi.org/10.1371/journal.ppat.1003483.
30. Sauter D. 2014. Counteraction of the multifunctional restriction factor tetherin. Front Microbiol 5:163. http://dx.doi.org/10.3389/fmicb.2014.00163.
31. McNatt MW, Zang T, Bieniasz PD. 2013. Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog 9:e1003299. http://dx.doi.org/10.1371/journal.ppat.1003299.
32. Vigan R, Neil SJ. 2010. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J Virol 84:12958-12970. http://dx.doi.org/10.1128/JVI.01699-10.
33. Goffinet C, Allespach I, Homann S, Tervo HM, Habermann A, Rupp D, Oberbremer L, Kern C, Tibroni N, Welsch S, Krijnse-Locker J, Banting G, Krausslich HG, Fackler OT, Keppler OT. 2009. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5:285-297. http://dx.doi.org/10.1016/j.chom.2009.01.009.
34. Goffinet C, Homann S, Ambiel I, Tibroni N, Rupp D, Keppler OT, Fackler OT. 2010. Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. J Virol 84:4089-4094. http://dx.doi.org/10.1128/JVI.01549-09.
35. Miyagi E, Andrew AJ, Kao S, Strebel K. 2009. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci USA 106:2868-2873. http://dx.doi.org/10.1073/pnas.0813223106.
36. Tervo HM, Homann S, Ambiel I, Fritz JV, Fackler OT, Keppler OT. 2011. beta-TrCP is dispensable for Vpu's ability to overcome the CD317/ Tetherin-imposed restriction to HIV-1 release. Retrovirology 8:9. http://dx.doi.org/10.1186/1742-4690-8-9.
37. Roy N, Pacini G, Berlioz-Torrent C, Janvier K. 2014. Mechanisms underlying HIV-1 Vpu-mediated viral egress. Front Microbiol 5:177. http://dx.doi.org/10.3389/fmicb.2014.00177.
38. Jafari M, Guatelli J, Lewinski MK. 2014. Activities of transmitted/ founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release. J Virol 88:5062-5078. http://dx.doi.org/10.1128/JVI.03472-13.
39. Lewinski MK, Jafari M, Zhang H, Opella SJ, Guatelli J. 2015. Membrane anchoring by a C-terminal tryptophan enables HIV-1 Vpu to displace bone marrow stromal antigen 2 (BST2) from sites of viral assembly. J Biol Chem 290:10919-10933. http://dx.doi.org/10.1074/jbc.M114.630095.
40. Schmidt S, Fritz JV, Bitzegeio J, Fackler OT, Keppler OT. 2011. HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. mBio 2:e00036-11. http://dx.doi.org/10.1128/mBio.00036-11.
41. Dube M, Paquay C, Roy BB, Bego MG, Mercier J, Cohen EA. 2011. HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface. Traffic 12:1714-1729. http://dx.doi.org/10.1111/j.1600-0854.2011.01277.x.
42. Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM. 2010. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 7:51. http://dx.doi.org/10.1186/1742-4690-7-51.
43. Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V. 2009. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its [H9252]-TrCP2-dependent degradation. PLoS Pathog 5:e1000574. http://dx.doi.org/10.1371/journal.ppat.1000574.
44. Schindler M, Rajan D, Banning C, Wimmer P, Koppensteiner H, Iwanski A, Specht A, Sauter D, Dobner T, Kirchhoff F. 2010. Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology 7:1. http://dx.doi.org/10.1186/1742-4690-7-1.
45. Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, Moses AV. 2009. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a [H9252]TrCP-dependent mechanism. J Virol 83:7931-7947. http://dx.doi.org/10.1128/JVI.00242-09.
46. Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC. 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 5:e1000450. http://dx.doi.org/10.1371/journal.ppat.1000450.
47. Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R. 1998. A novel human WD protein, h-[H9252] TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1:565-574. http://dx.doi.org/10.1016/S1097-2765(00)80056-8.
48. Binette J, Dube M, Mercier J, Halawani D, Latterich M, Cohen EA. 2007. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 4:75. http://dx.doi.org/10.1186/1742-4690-4-75.
49. Janvier K, Roy N, Berlioz-Torrent C. 2012. Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin. Curr HIV Res 10:315-320. http://dx.doi.org/10.2174/157016212800792414.
50. Schubert U, Schneider T, Henklein P, Hoffmann K, Berthold E, Hauser H, Pauli G, Porstmann T. 1992. Human immunodeficiency virus type 1-en-coded Vpu protein is phosphorylated by casein kinase II. Eur J Biochem 204: 875-883. http://dx.doi.org/10.1111/j.1432-1033.1992.tb16707.x.
51. Kueck T, Foster TL, Weinelt J, Sumner JC, Pickering S, Neil SJ. 2015. Serine phosphorylation of HIV-1 Vpu and its binding to tetherin regulates interaction with clathrin adaptors. PLoS Pathog 11:e1005141. http://dx.doi.org/10.1371/journal.ppat.1005141.
52. Jia X, Weber E, Tokarev A, Lewinski M, Rizk M, Suarez M, Guatelli J, Xiong Y. 2014. Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1. Elife 3:e02362. http://dx.doi.org/10.7554/eLife.02362.
53. Magadan JG, Perez-Victoria FJ, Sougrat R, Ye Y, Strebel K, Bonifacino JS. 2010. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog 6:e1000869. http://dx.doi.org/10.1371/journal.ppat.1000869.
54. Fritz JV, Tibroni N, Keppler OT, Fackler OT. 2012. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin. Virology 424:33-44. http://dx.doi.org/10.1016/j.virol.2011.12.008.
55. Kueck T, Neil SJ. 2012. A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog 8:e1002609. http://dx.doi.org/10.1371/journal.ppat.1002609.
56. Lampe M, Briggs JA, Endress T, Glass B, Riegelsberger S, Krausslich HG, Lamb DC, Brauchle C, Muller B. 2007. Double-labeled HIV-1 particles for study of virus-cell interaction. Virology 360:92-104. http://dx.doi.org/10.1016/j.virol.2006.10.005.
57. Kluge SF, Mack K, Iyer SS, Pujol FM, Heigele A, Learn GH, Usmani SM, Sauter D, Joas S, Hotter D, Bibollet-Ruche F, Plenderleith LJ, Peeters M, Geyer M, Sharp PM, Fackler OT, Hahn BH, Kirchhoff F. 2014. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 16:639-650. http://dx.doi.org/10.1016/j.chom.2014.10.002.
58. Trotard M, Tsopoulidis N, Tibroni N, Willemsen J, Binder M, Ruggieri A, Fackler OT. 2015. Sensing of HIV-1 infection in Tzm-bl cells with reconstituted expression of STING. J Virol 90:2064-2076. http://dx.doi.org/10.1128/JVI.02966-15.
59. Zhang F, Zang T, Wilson SJ, Johnson MC, Bieniasz PD. 2011. Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog 7:e1002119. http://dx.doi.org/10.1371/journal.ppat.1002119.
60. Fackler OT, Moris A, Tibroni N, Giese SI, Glass B, Schwartz O, Krausslich HG. 2006. Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351:322-339. http://dx.doi.org/10.1016/j.virol.2006.03.044.
61. Senis E, Fatouros C, Grosse S, Wiedtke E, Niopek D, Mueller AK, Borner K, Grimm D. 2014. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. Biotechnol J 9:1402-1412. http://dx.doi.org/10.1002/biot.201400046.
62. Yoshida T, Koyanagi Y, Strebel K. 2013. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions. J Virol 87:13825-13836. http://dx.doi.org/10.1128/JVI.02567-13.
63. Dube M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, Leung G, Cohen EA. 2009. Suppression of tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol 83:4574-4590. http://dx.doi.org/10.1128/JVI.01800-08.
64. Ivanchenko S, Godinez WJ, Lampe M, Krausslich HG, Eils R, Rohr K, Brauchle C, Muller B, Lamb DC. 2009. Dynamics of HIV-1 assembly and release. PLoS Pathog 5:e1000652. http://dx.doi.org/10.1371/journal.ppat.1000652.
65. Ma D, Taneja TK, Hagen BM, Kim BY, Ortega B, Lederer WJ, Welling PA. 2011. Golgi export of the Kir2.1 channel is driven by a trafficking signal located within its tertiary structure. Cell 145:1102-1115. http://dx.doi.org/10.1016/j.cell.2011.06.007.
66. Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, Gibson A, Hopkins CR, Evans PR, McMahon HT. 2001. Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 291:1051-1055. http://dx.doi.org/10.1126/science.291.5506.1051.
67. Lau D, Kwan W, Guatelli J. 2011. Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens. J Virol 85:9834-9846. http://dx.doi.org/10.1128/JVI.02633-10.
68. Park SY, Guo X. 2014. Adaptor protein complexes and intracellular transport. Biosci Rep 34:e00123. http://dx.doi.org/10.1042/BSR20140069.
69. Guo X, Mattera R, Ren X, Chen Y, Retamal C, Gonzalez A, Bonifacino JS. 2013. The adaptor protein-1 [H9262]1B subunit expands the repertoire of basolateral sorting signal recognition in epithelial cells. Dev Cell 27:353-366. http://dx.doi.org/10.1016/j.devcel.2013.10.006.